CVR 40036075Entrepreneurial company (IVS)Tømrer- og bygningssnedkervirksomhed (433200)Nykøbing SjFounded 20 Nov 2018
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about BioTech.dk IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexRevenue
0
DKK, annual report 2019
Result
0
DKK, annual report 2019
Equity
100
DKK, annual report 2019
BioTech Holding. dk ApSCVR 38241672, 100% of capital and votes, until 28 Sep 2021
Torben Christensenuntil 18 Aug 2021
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 37421537100% of capital and votesnotified 10 Jun 202020 Nov 2018 to 1 Jun 2020
CVR 3755390550% to under 66.7% of capital and votesnotified 10 Jun 20201 Jun 2020 to 1 Jun 2020
CVR 38241672100% of capital and votesnotified 10 Jun 20201 Jun 2020 to 28 Sep 2021
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
20 Nov 2018 to 14 Nov 2026.
| Metric | 2019 |
|---|---|
| Revenue | 0 |
| Operating profit | 0 |
| Result for the year | 0 |
| Equity | 0 |
| Total assets | 0 |
| Credit metrics (Dandex calculations) | |
| EBITDA | 0 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
DKK thousands. Annual reports via XBRL. 2019 covers 13 months (20 Nov 2018 to 31 Dec 2019).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For BioTech.dk IVS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 14 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 14 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
7 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Skifteretsbehandlingen sluttet, virksomheden er opløst
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Skifteretten i Holbæk den 18.08.2021
Direktion:
Fratrådte:
Torben Christensen, (adm. dir), den 18.08.2021.
Ny adresse: Egebjerg Hovedgade 27, Egebjerg, 4500 Nykøbing Sj
Ny kommune: Odsherred
Vedtægter ændret: 06.05.2020
Nyt navn: BioTech.dk IVS
Direktion:
Fratrådte:
Jacob Kuno Martinsen, den 19.06.2019.
Stiftelsesdato: 20.11.2018.
Virkningsdato: 20.11.2018.
Seneste vedtægtsdato: 20.11.2018.
Kapital:
kr. 1.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 37421537 C&L Holding IVS, Nybyvej 13, 4390 Vipperød, den 20.11.2018.
Direktion:
Jacob Kuno Martinsen, den 20.11.2018.
Selskabet tegnes af en direktør..
Første regnskabsår:
20.11.2018 - 31.12.2019.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udføre byggeservice, herunder tømrer-, maler-, og murerarbejde samt anden hermed beslægtet virksomhed.
1 registered in CVR.
P-number 1024148676Egebjerg Hovedgade 27, 4500 Nykøbing Sj